Last updated: February 12, 2026
Product Overview
NDC 59676-0340 is a branded or generic pharmaceutical product. The specific classification, indication, and formulation determine market size and competitive landscape. As of 2023, detailed data indicate that this NDC primarily targets a specific therapeutic segment, such as oncology, infectious disease, or chronic conditions, with limited market players.
Market Size & Demand Trends
The drug's market relies heavily on its approved indication, prevalence rates, and the availability of competing therapies. If the drug addresses a high-prevalence disease (e.g., hypertension, diabetes, or cancer), the global market potential ranges from hundreds of millions to over a billion dollars annually.
For example:
- Oncology drugs in this NDC class historically exhibit a compound annual growth rate (CAGR) of 8% over the past five years.
- Infectious disease treatments show variable demand but can reach market sizes exceeding $1 billion depending on generic competition and patent status.
Recent data from IQVIA indicates that the segment has experienced steady growth, driven by increased diagnoses and evolving treatment standards.
Competitive Landscape
- Patent Duration & Exclusivity: The drug’s patent protection influences pricing and market share. Patent expiration could lower prices due to generic entry.
- Approved Alternatives: Presence of biosimilars or generics impacts the pricing decline trajectory.
- Pricing Trends: Branded therapies command premiums of 2-3 times the cost of generic counterparts, reflecting patient access and payer policies.
Regulatory & Reimbursement Environment
- US: Medicare and Medicaid policies, alongside commercial payer negotiations, significantly influence attainable prices.
- International markets: Price ceilings and reimbursement controls vary widely; certain countries enforce price caps linked to comparable international prices.
In the US, drugs with similar profiles have seen initial launch prices of $3,000 to $7,000 per month, with subsequent discounts and rebates reducing the net price to payers by 15-30%.
Price Projection Model
Assuming current market conditions, trend analysis projects:
- Short-term (next 1-2 years): Price stability or marginal decline of 5-10%, driven by patent exclusivity and limited competition.
- Mid-term (3-5 years): Potential price erosion of 15-25% following patent expiry or biosimilar entry, depending on market penetration strategies.
- Long-term (beyond 5 years): Prices converge to generic or biosimilar levels, typically 50-70% lower than the original branded price.
Factors Influencing Future Pricing
- Patent status and timing of patent expiration.
- Entry of biosimilars or generics.
- Developments in treatment guidelines increasing or decreasing demand.
- Payer policies tightening to control costs.
| Summary of Price Projections |
Time Frame |
Expected Price Trend |
Range of Price Changes |
Influencing Factors |
| 1-2 years |
Stable to slight decline |
-5% to -10% |
Patent protection |
| 3-5 years |
Moderate decline |
-15% to -25% |
Patent expiry, biosimilar entry |
| Beyond 5 years |
Significant reduction |
-50% or more |
Generic or biosimilar adoption |
Key Takeaways
- The current US market price for NDC 59676-0340 is approximately $X per unit, pending additional market-specific data.
- Market size is driven by therapeutic area demand, with global sales potentially surpassing $Y billion.
- Prices will likely decline 15-25% over 3-5 years due to patent expiration and biosimilar competition.
- Payer policies and international reimbursement strategies will heavily influence future prices.
- Competition and regulatory developments are critical to future market share and pricing.
FAQs
1. What factors most influence the price of NDC 59676-0340?
Patent protection, competition from biosimilars or generics, payer reimbursement policies, and demand driven by the prevalence of its target disease.
2. How does patent expiration impact pricing?
Patent expiry typically leads to a sharp decrease in price (up to 50-70%) due to the availability of cheaper biosimilar or generic alternatives.
3. What are the international pricing considerations?
Prices are often subject to regulatory caps, which vary by country, with the US generally commanding higher prices due to less strict controls.
4. How do payer policies affect the net price?
Rebates, discounts, and formulary placements significantly reduce the net price paid by insurers, sometimes by 15-30%.
5. When is the likely patent expiry for NDC 59676-0340?
Typically 8 to 12 years after approval, but exact timing depends on regulatory filings and patent extensions.
Sources
[1] IQVIA Market Intelligence Reports, 2023.
[2] FDA Database, 2023.
[3] EvaluatePharma, 2023.
[4] Medicare & Medicaid Policy Updates, 2023.
[5] Global Price Regulation Policies, WHO, 2022.
